<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 16:19:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 16  Filed by: Allan Jonathan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+16++Filed+by%3A+Allan+Jonathan/26666337.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666337.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+16++Filed+by%3A+Allan+Jonathan/26666337.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 16  Filed by: Allan Jonathan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+16++Filed+by%3A+Allan+Jonathan/26666337.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666337.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+16++Filed+by%3A+Allan+Jonathan/26666337.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  144        Stoke Therapeutics, Inc.               Filed by: Allan Jonathan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Stoke+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Allan+Jonathan/26654603.html</link>
   <description>si-local-file:///var/storage/secattach/20260616/26654603.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Stoke+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Allan+Jonathan/26654603.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  144        Stoke Therapeutics, Inc.               Filed by: Allan Jonathan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Stoke+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Allan+Jonathan/26654603.html</link>
   <description>si-local-file:///var/storage/secattach/20260616/26654603.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Stoke+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Allan+Jonathan/26654603.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</link>
   <description>
&lt;p&gt;    BEDFORD, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stoketherapeutics.com%2F&amp;amp;esheet=54555333&amp;amp;newsitemid=20260616970646&amp;amp;lan=en-US&amp;amp;anchor=Stoke+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=0f33468c37babc41718840dcdc7fd0c4&quot; shape=&quot;rect&quot;&gt;Stoke Therapeutics, Inc.&lt;/a&gt; (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 15, 2026, it granted stock options to purchase an aggregate of 103,020 shares of common stock to nine new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

&lt;/p&gt;&lt;p&gt;
The stock options that were granted have an exercise</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</link>
   <description>
&lt;p&gt;    BEDFORD, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stoketherapeutics.com%2F&amp;amp;esheet=54555333&amp;amp;newsitemid=20260616970646&amp;amp;lan=en-US&amp;amp;anchor=Stoke+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=0f33468c37babc41718840dcdc7fd0c4&quot; shape=&quot;rect&quot;&gt;Stoke Therapeutics, Inc.&lt;/a&gt; (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 15, 2026, it granted stock options to purchase an aggregate of 103,020 shares of common stock to nine new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

&lt;/p&gt;&lt;p&gt;
The stock options that were granted have an exercise</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Business+Wire/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</link>
   <description>
&lt;p&gt;    BEDFORD, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stoketherapeutics.com%2F&amp;amp;esheet=54555333&amp;amp;newsitemid=20260616970646&amp;amp;lan=en-US&amp;amp;anchor=Stoke+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=0f33468c37babc41718840dcdc7fd0c4&quot; shape=&quot;rect&quot;&gt;Stoke Therapeutics, Inc.&lt;/a&gt; (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 15, 2026, it granted stock options to purchase an aggregate of 103,020 shares of common stock to nine new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

&lt;/p&gt;&lt;p&gt;
The stock options that were granted have an exercise</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Business+Wire/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</link>
   <description>
&lt;p&gt;    BEDFORD, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stoketherapeutics.com%2F&amp;amp;esheet=54555333&amp;amp;newsitemid=20260616970646&amp;amp;lan=en-US&amp;amp;anchor=Stoke+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=0f33468c37babc41718840dcdc7fd0c4&quot; shape=&quot;rect&quot;&gt;Stoke Therapeutics, Inc.&lt;/a&gt; (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 15, 2026, it granted stock options to purchase an aggregate of 103,020 shares of common stock to nine new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).

&lt;/p&gt;&lt;p&gt;
The stock options that were granted have an exercise</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Stoke+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26653906.html</guid>
   <pubDate>Tue, 16 Jun 2026 16:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: TZIANABOS ARTHUR</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+TZIANABOS+ARTHUR/26611638.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611638.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+TZIANABOS+ARTHUR/26611638.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: TZIANABOS ARTHUR</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+TZIANABOS+ARTHUR/26611638.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611638.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+TZIANABOS+ARTHUR/26611638.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Smith Julie</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Smith+Julie/26611601.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611601.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Smith+Julie/26611601.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Smith Julie</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Smith+Julie/26611601.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611601.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Smith+Julie/26611601.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: LEVIN ARTHUR A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+LEVIN+ARTHUR+A/26611558.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611558.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+LEVIN+ARTHUR+A/26611558.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: LEVIN ARTHUR A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+LEVIN+ARTHUR+A/26611558.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611558.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+LEVIN+ARTHUR+A/26611558.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Krainer Adrian R.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Krainer+Adrian+R./26611486.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611486.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Krainer+Adrian+R./26611486.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Krainer Adrian R.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Krainer+Adrian+R./26611486.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611486.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Krainer+Adrian+R./26611486.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Kaye Edward M. MD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Kaye+Edward+M.+MD/26611470.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611470.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Kaye+Edward+M.+MD/26611470.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Kaye Edward M. MD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Kaye+Edward+M.+MD/26611470.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611470.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Kaye+Edward+M.+MD/26611470.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Harrison Seth Loring</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Harrison+Seth+Loring/26611447.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611447.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Harrison+Seth+Loring/26611447.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Harrison Seth Loring</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Harrison+Seth+Loring/26611447.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611447.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Harrison+Seth+Loring/26611447.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Burstein Jennifer</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Burstein+Jennifer/26611416.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611416.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Burstein+Jennifer/26611416.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 03  Filed by: Burstein Jennifer</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Burstein+Jennifer/26611416.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26611416.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03++Filed+by%3A+Burstein+Jennifer/26611416.html</guid>
   <pubDate>Fri, 05 Jun 2026 16:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  8-K        Stoke Therapeutics, Inc.  For: Jun 03</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03/26605693.html</link>
   <description>si-local-file:///var/storage/secattach/20260604/26605693.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03/26605693.html</guid>
   <pubDate>Thu, 04 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  8-K        Stoke Therapeutics, Inc.  For: Jun 03</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03/26605693.html</link>
   <description>si-local-file:///var/storage/secattach/20260604/26605693.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+03/26605693.html</guid>
   <pubDate>Thu, 04 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
  <item>
   <title>Form  4          Stoke Therapeutics, Inc.  For: Jun 01  Filed by: Ticho Barry</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+01++Filed+by%3A+Ticho+Barry/26600535.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26600535.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Stoke+Therapeutics%2C+Inc.++For%3A+Jun+01++Filed+by%3A+Ticho+Barry/26600535.html</guid>
   <pubDate>Wed, 03 Jun 2026 17:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.41203217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STOK</category>
   	  </item>
 </channel>
</rss>
